Laboratory of Bioimaging and Pathology | LBP | UMR 7021

Nucleic Acid Aptamersfor Bacterial Detection and Bioimaging

In a new article published in the Journal of Medicinal Chemistry, Chaimae Mezouarhi under the supervision of  Laurence Choulier, Pierre Fechter of the BSC Laboratory (UMR7242 University of Strasbourg/CNRS), and their collaborators explore the landscape of aptamers targeting bacteria, their applications in bioimaging (dynamic imaging, theranostics,…

Pharma Site Science Day : When CBST, LIT, LBP, and CambaP Share Their Latest Advances !

On Friday, October 9, 2026, the Laustriat Auditorium at the Faculty of Pharmacy hosted the Pharma Campus Units’ Scientific Day, bringing together teams from the UMR CBST (7199), LIT (7200), LBP (7021) and CambaP (7178). The day was marked by collaboration, discovery, and synergy, with active participation from all units, including the CambaP team,…

CDKN2A Alterations in Solid Tumors

The OnKO•3T team is pleased to announce the publication of a comprehensive review in the journal *Histology and Histopathology*, titled : "CDKN2A alterations in solid tumors: From biological mechanisms to clinical applications, with special emphasis on central nervous system tumors". The CDKN2A gene, a major tumor suppressor, plays a central role…

New BODIPY-based fluorescent probes improve fluorescence lifetime imaging

Yelyzaveta Denysieva and Dmytro Dziuba, together with Ludovic Richert and Yves Mély from the BIMC team and Julie Karpenko from the LIT, have recently published a study on the development of improved fluorescent probes for fluorescence lifetime imaging microscopy (FLIM). The team investigated BODIPY-based fluorescent molecular rotors, a class of…

The Laboratory of Bioimaging and Pathology

The aim of the Laboratory of Bioimaging and Pathology is to use multidisciplinary (biology/chemistry/physics) and multi-scale (from molecule to patient) approaches to study, at both fundamental and applied levels, the properties and roles of a limited number of key biomolecules involved in various pathological processes. Our approach is to develop new therapeutic and diagnostic approaches in oncology and microbiology based on information obtained at the fundamental level. A key feature of the unit is the parallel development and characterisation of innovative fluorescence-based tools, methods and techniques to answer these questions. This multidisciplinary approach, which combines the development of innovative fluorescence and imaging tools to address biological questions, is unique in the French scientific landscape.

Lire la suite

News

Publications